Alligator Bioscience AB (publ) (STO:ATORX)
Sweden · Delayed Price · Currency is SEK 0.2405
+0.0200 (9.07%)
Apr 24, 2026, 5:29 PM CET
Alligator Bioscience AB Market Cap
Alligator Bioscience AB has a market cap or net worth of 151.06 million as of April 24, 2026. Its market cap has increased by 46.48% in one year.
Market Cap
151.06M
Enterprise Value
132.01M
Revenue
839.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
Market Cap Chart
Since November 23, 2016, Alligator Bioscience AB's market cap has decreased from 2.67B to 151.06M, a decrease of -94.34%. That is a compound annual growth rate of -26.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 138.50M | 838.28% |
| Dec 30, 2025 | 14.76M | -92.20% |
| Dec 30, 2024 | 189.17M | -58.27% |
| Dec 29, 2023 | 453.33M | 32.59% |
| Dec 30, 2022 | 341.91M | -39.69% |
| Dec 30, 2021 | 566.90M | -0.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Initiator Pharma | 219.05M |
| Isofol Medical AB | 218.25M |
| Xbrane Biopharma AB | 193.69M |
| Active Biotech AB | 175.03M |
| Diamyd Medical AB | 170.48M |
| AlzeCure Pharma AB | 156.28M |
| Elicera Therapeutics AB | 156.04M |
| NextCell Pharma AB | 130.33M |